TP53 and cancer: Impairing the functions of E6 through an inhibitory small-molecule compound could have profound effects on the survival of cancer cells due to the reactivation of p53-mediated pathways and thus represents a fascinating strategy for the treatment of HPV-associated neoplasias41,42.